Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Severe Exogenous Lipoid Pneumonia Following Ingestion of Large Dose Squalene: Successful Treatment with Steroid

Choi HS, Kwag HJ, Chae SW, Lim SY, Lim SY

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):235-238.
Exogenous lipoid pneumonia (ELP) is an uncommon condition resulting from aspiration or inhalation of vegetable, animal or mineral oil. It results in foreign body type inflammatory reaction of the lung...
Clinical Characteristics of Intensive Care Unit Patients with Carbapenem Resistant Acinetobacter Baumannii Isolated from Sputum

Lee SW, Jo HS, Kim WJ

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):228-234.
BACKGROUND: Acinetobacter baumannii is an important pathogen associated with nosocomial infections in intensive care units, and is responsible for nosocomial pneumonia, UTI, bacteremia, etc. The main concern is that this...
The Role of Inhaled Corticosteroid in the Management of Chronic Cough

Lee KH, Jang SH, Lee JH, Eom KS, Bahn JW, Kim DG, Shin TR, Park SM, Lee MG, Kim CH, Hyun IG, Jung KS

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):221-227.
BACKGROUND: Cough may be a consequence of bronchial hyperresponsiveness or inflammation. Empirical treatment is important in this context because it difficult to verify the obvious cause of cough using laboratory...
Effect of a New Spirometric Reference Equation on the Interpretation of Spirometric Patterns and Disease Severity

Oh YM, Hong SB, Shim TS, Lim CM, Koh Y, Kim WS, Kim DS, Kim WD, Kim YS, Lee SD

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):215-220.
BACKGROUND: A spirometric reference equation was recently developed for the general population in Korea. The applicability of the new Korean equation to clinical practice was examined by comparing it with...
Predictors of Long-term Mortality after Hospitalization for Acute Exacerbation of COPD

Jung HS, Lee JH, Chun EM, Moon JW, Chang JH

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):205-214.
BACKGROUND: Acute exacerbations form a major component of the socioeconomic burden of COPD. As yet, little information is available about the long-term outcome of patients who have been hospitalized with...
The Clinical Characteristics, Diagnosis, Treatment, and Outcomes of Patients with Tuberculosis at a Private University Hospital in Korea

Jung YJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):194-204.
BACKGROUND: Even though tuberculosis (TB) is still a major public concern in Korea, there is little data on the management of TB patients and its outcomes in the private sector....
Investigation of the Growth Rate Change in Recombinant BCG which was cloned Mycobacterium tuberculosis Adenylate Kinase Mutation Gene or Human Muscle-type Adenylate Kinase Synthetic Gene

Lee SH, Kim HJ, Park YK, Bai GH

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):187-193.
BACKGROUND: Normal cell proliferation and viability is strongly depends on the availability of metabolic energy and the maintenance of the appropriate adenylate-nucleotide pools. Hypothetically, changes in adenylate kinase (AK) expression...
A Retrospective Study for Relapse Rate According to the Discontinuance of Para-aminosalicylic acid(PAS) after Bacteriological Conversion during the Course of Chemotherapy for Multidrug-Resistant Tuberculosis(MDR-TB)

Park SK, Kim BJ, Shin DO, Jun BY

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):180-186.
BACKGROUND: Para-aminosalicylic acid(PAS) is a 2nd-line drug that can cause severe adverse reactions leading to poor patient compliance. This study evaluated the relapse rate according to the discontinuance of PAS...
Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains

Kim BJ, Oh SH, Cho EJ, Park SK

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):171-179.
BACKGROUND: Despite the emerging danger of MDR-TB to human beings, there have only been a limited number of drugs developed to treat MDR-TB since 1970. This study investigated the cross-resistance...
p16(INK4a) Promoter Hypermethylation in Sputum, Blood, and Tissue from Non-Small Cell Lung Cancer and Pulmonary Inflammation

Kim JP, Kim KM, Kwon SS, Kim YK, Kim KH, Moon HS, Song JS, Park SH, Ahn JH

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):160-170.
BACKGROUND: The aberrant promoter hypermethylation of p16(INK4a), as a tumor suppressor gene, is contributory factor to non-small cell lung cancer(NSCLC). However, its potential diagnostic impact of lung cancer is unclear....
Relation between ERCC1 Expression in Sputum and Survival after Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer

Yang SW, Choi PR, You HJ, Kim JG, Oak CH, Jang TW, Jung MH

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):151-159.
BACKGROUND: Excision repair cross complementing gene 1 (ERCC1) not only has a protective role against carcinogens, but plays an important role in cisplatin-resistance via the repair of cisplatin-DNA adducts. This...
Medeical Therapy For Pulmonary Arterial Hypertention

Choi HS, Lee SD

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):142-150.
Pulmonary arterial hypertension (PAH) is often difficult to diagnose and challenging to treat. Untreated, it is characterized by a progressive increase in pulmonary vascular resistance leading to right ventricular failure...
Drugs for Lung Cancer Treatment

Kim YC, Kim KS

  • Tuberc Respir Dis.
  • 2006 Feb;60(2):123-141.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr